ARRHYTHMIA RESH TECHNOLOGY I's ticker is HRT and the CUSIP is 042698308. A total of 11 filers reported holding ARRHYTHMIA RESH TECHNOLOGY I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $102,000 | -8.9% | 26,800 | 0.0% | 0.00% | – |
| Q3 2016 | $112,000 | -5.1% | 26,800 | 0.0% | 0.00% | – |
| Q2 2016 | $118,000 | +3.5% | 26,800 | 0.0% | 0.00% | – |
| Q1 2016 | $114,000 | -22.4% | 26,800 | 0.0% | 0.00% | – |
| Q4 2015 | $147,000 | -12.0% | 26,800 | 0.0% | 0.00% | – |
| Q3 2015 | $167,000 | -0.6% | 26,800 | 0.0% | 0.00% | – |
| Q2 2015 | $168,000 | -15.2% | 26,800 | 0.0% | 0.00% | – |
| Q1 2015 | $198,000 | 0.0% | 26,800 | 0.0% | 0.00% | – |
| Q4 2014 | $198,000 | +11.2% | 26,800 | 0.0% | 0.00% | – |
| Q3 2014 | $178,000 | 0.0% | 26,800 | 0.0% | 0.00% | – |
| Q2 2014 | $178,000 | +29.9% | 26,800 | 0.0% | 0.00% | – |
| Q1 2014 | $137,000 | +26.9% | 26,800 | 0.0% | 0.00% | – |
| Q4 2013 | $108,000 | +50.0% | 26,800 | 0.0% | 0.00% | – |
| Q3 2013 | $72,000 | +2.9% | 26,800 | 0.0% | 0.00% | – |
| Q2 2013 | $70,000 | – | 26,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 91,000 | $499,000 | 0.00% |
| FMR LLC | 90,300 | $495,000 | 0.00% |
| Nationwide Fund Advisors | 200 | $1,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 59,223 | $325,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 90 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| UBS Group AG | 2,242 | $12,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 100 | $1,000 | 0.00% |
| Bank of New York Mellon Corp | 12,080 | $66,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 462 | $3,000 | 0.00% |